IDEXX LABORATORIES INC (IDXX) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IDXX • US45168D1046

670.46 USD
-6.25 (-0.92%)
At close: Jan 30, 2026
670.46 USD
0 (0%)
After Hours: 1/30/2026, 8:00:02 PM
Fundamental Rating

7

Taking everything into account, IDXX scores 7 out of 10 in our fundamental rating. IDXX was compared to 184 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making IDXX a very profitable company, without any liquidiy or solvency issues. IDXX has a correct valuation and a medium growth rate. With these ratings, IDXX could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year IDXX was profitable.
  • IDXX had a positive operating cash flow in the past year.
  • Each year in the past 5 years IDXX has been profitable.
  • IDXX had a positive operating cash flow in each of the past 5 years.
IDXX Yearly Net Income VS EBIT VS OCF VS FCFIDXX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • With an excellent Return On Assets value of 30.34%, IDXX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 65.81%, IDXX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IDXX's Return On Invested Capital of 40.25% is amongst the best of the industry. IDXX outperforms 100.00% of its industry peers.
  • IDXX had an Average Return On Invested Capital over the past 3 years of 35.08%. This is significantly above the industry average of 8.81%.
  • The 3 year average ROIC (35.08%) for IDXX is below the current ROIC(40.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 30.34%
ROE 65.81%
ROIC 40.25%
ROA(3y)25.87%
ROA(5y)26.7%
ROE(3y)74.71%
ROE(5y)84.83%
ROIC(3y)35.08%
ROIC(5y)36.07%
IDXX Yearly ROA, ROE, ROICIDXX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

  • IDXX has a better Profit Margin (24.65%) than 95.65% of its industry peers.
  • In the last couple of years the Profit Margin of IDXX has grown nicely.
  • IDXX's Operating Margin of 31.34% is amongst the best of the industry. IDXX outperforms 98.91% of its industry peers.
  • IDXX's Operating Margin has improved in the last couple of years.
  • IDXX has a Gross Margin of 61.72%. This is in the better half of the industry: IDXX outperforms 63.59% of its industry peers.
  • IDXX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 31.34%
PM (TTM) 24.65%
GM 61.72%
OM growth 3Y0.02%
OM growth 5Y4.78%
PM growth 3Y-0.56%
PM growth 5Y5.09%
GM growth 3Y1.27%
GM growth 5Y1.47%
IDXX Yearly Profit, Operating, Gross MarginsIDXX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

  • IDXX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for IDXX has been reduced compared to 1 year ago.
  • IDXX has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for IDXX has been reduced compared to a year ago.
IDXX Yearly Shares OutstandingIDXX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IDXX Yearly Total Debt VS Total AssetsIDXX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • IDXX has an Altman-Z score of 22.72. This indicates that IDXX is financially healthy and has little risk of bankruptcy at the moment.
  • IDXX's Altman-Z score of 22.72 is amongst the best of the industry. IDXX outperforms 96.20% of its industry peers.
  • The Debt to FCF ratio of IDXX is 1.04, which is an excellent value as it means it would take IDXX, only 1.04 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of IDXX (1.04) is better than 90.22% of its industry peers.
  • A Debt/Equity ratio of 0.53 indicates that IDXX is somewhat dependend on debt financing.
  • IDXX has a Debt to Equity ratio (0.53) which is in line with its industry peers.
  • Although IDXX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 1.04
Altman-Z 22.72
ROIC/WACC3.84
WACC10.49%
IDXX Yearly LT Debt VS Equity VS FCFIDXX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.18 indicates that IDXX should not have too much problems paying its short term obligations.
  • IDXX's Current ratio of 1.18 is on the low side compared to the rest of the industry. IDXX is outperformed by 81.52% of its industry peers.
  • IDXX has a Quick Ratio of 1.18. This is a bad value and indicates that IDXX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IDXX has a Quick ratio of 0.87. This is in the lower half of the industry: IDXX underperforms 79.89% of its industry peers.
  • The current and quick ratio evaluation for IDXX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.87
IDXX Yearly Current Assets VS Current LiabilitesIDXX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

6

3. Growth

3.1 Past

  • IDXX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.16%, which is quite good.
  • The Earnings Per Share has been growing by 18.18% on average over the past years. This is quite good.
  • Looking at the last year, IDXX shows a quite strong growth in Revenue. The Revenue has grown by 8.39% in the last year.
  • Measured over the past years, IDXX shows a quite strong growth in Revenue. The Revenue has been growing by 10.12% on average per year.
EPS 1Y (TTM)15.16%
EPS 3Y9.32%
EPS 5Y18.18%
EPS Q2Q%21.43%
Revenue 1Y (TTM)8.39%
Revenue growth 3Y6.62%
Revenue growth 5Y10.12%
Sales Q2Q%13.29%

3.2 Future

  • IDXX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.18% yearly.
  • The Revenue is expected to grow by 9.43% on average over the next years. This is quite good.
EPS Next Y16.89%
EPS Next 2Y14.65%
EPS Next 3Y14.13%
EPS Next 5Y14.18%
Revenue Next Year10.46%
Revenue Next 2Y9.59%
Revenue Next 3Y9.39%
Revenue Next 5Y9.43%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IDXX Yearly Revenue VS EstimatesIDXX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
IDXX Yearly EPS VS EstimatesIDXX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 53.17, which means the current valuation is very expensive for IDXX.
  • Compared to the rest of the industry, the Price/Earnings ratio of IDXX indicates a somewhat cheap valuation: IDXX is cheaper than 69.57% of the companies listed in the same industry.
  • IDXX is valuated expensively when we compare the Price/Earnings ratio to 28.30, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 45.34, the valuation of IDXX can be described as expensive.
  • 69.02% of the companies in the same industry are more expensive than IDXX, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.57, IDXX is valued quite expensively.
Industry RankSector Rank
PE 53.17
Fwd PE 45.34
IDXX Price Earnings VS Forward Price EarningsIDXX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IDXX is valued a bit cheaper than the industry average as 67.39% of the companies are valued more expensively.
  • 72.28% of the companies in the same industry are more expensive than IDXX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 56.94
EV/EBITDA 37.24
IDXX Per share dataIDXX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of IDXX may justify a higher PE ratio.
  • A more expensive valuation may be justified as IDXX's earnings are expected to grow with 14.13% in the coming years.
PEG (NY)3.15
PEG (5Y)2.92
EPS Next 2Y14.65%
EPS Next 3Y14.13%

0

5. Dividend

5.1 Amount

  • No dividends for IDXX!.
Industry RankSector Rank
Dividend Yield 0%

IDEXX LABORATORIES INC / IDXX FAQ

What is the ChartMill fundamental rating of IDEXX LABORATORIES INC (IDXX) stock?

ChartMill assigns a fundamental rating of 7 / 10 to IDXX.


What is the valuation status of IDEXX LABORATORIES INC (IDXX) stock?

ChartMill assigns a valuation rating of 4 / 10 to IDEXX LABORATORIES INC (IDXX). This can be considered as Fairly Valued.


Can you provide the profitability details for IDEXX LABORATORIES INC?

IDEXX LABORATORIES INC (IDXX) has a profitability rating of 9 / 10.


What are the PE and PB ratios of IDEXX LABORATORIES INC (IDXX) stock?

The Price/Earnings (PE) ratio for IDEXX LABORATORIES INC (IDXX) is 53.17 and the Price/Book (PB) ratio is 34.29.


What is the expected EPS growth for IDEXX LABORATORIES INC (IDXX) stock?

The Earnings per Share (EPS) of IDEXX LABORATORIES INC (IDXX) is expected to grow by 16.89% in the next year.